|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yan T, Zhao J, Bi X, Zhao H, Huang Z, Li
ZY, Zhou JG, Li Y, Li C, Cai JQ and Zhao P: Prognosis of
hepatocenular carcinoma: A study of 832 cases. Zhong Hua Zhong Liu
Za Zhi. 35:54–58. 2013.(In Chinese).
|
|
4
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sherman M: Recurrence of hepatocellular
carcinoma. N Engl J Med. 359:2045–2047. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu M, Jiang L and Guan XY: The genetic
and epigenetic alterations in human hepatocellular carcinoma: A
recent update. Protein Cell. 5:673–691. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kishi Y, Hasegawa K, Sugawara Y and Kokudo
N: Hepatocellular carcinoma: Current management and future
development-improved outcomes with surgical resection. Int J
Hepatol. 2011:7281032011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shah SA, Cleary SP, Wei AC, Yang I, Taylor
BR, Hemming AW, Langer B, Grant DR, Greig PD and Gallinger S:
Recurrence after liver resection for hepatocellular carcinoma: Risk
factors, treatment, and outcomes. Surgery. 141:330–339. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roessler S, Jia HL, Budhu A, Forgues M, Ye
QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX and Wang XW: A
unique metastasis gene signature enables prediction of tumor
relapse in early-stage hepatocellular carcinoma patients. Cancer
Res. 70:10202–10212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fang Y, Xue JL, Shen Q, Chen J and Tian L:
MicroRNA-7 inhibits tumor growth and metastasis by targeting the
phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Hepatology. 55:1852–1862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mizuguchi Y, Mishima T, Yokomuro S, Arima
Y, Kawahigashi Y, Shigehara K, Kanda T, Yoshida H, Uchida E, Tajiri
T and Takizawa T: Sequencing and bioinformatics-based analyses of
the microRNA transcriptome in hepatitis B-related hepatocellular
carcinoma. PLoS One. 6:e153042011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang P, Ma Y, Wang F, Yang J, Liu Z, Peng
J and Qin H: Comprehensive gene and microRNA expression profiling
reveals the crucial role of hsa-let-7i and its target genes in
colorectal cancer metastasis. Mol Biol Rep. 39:1471–1478. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stewart SE, Yu D, Scharf JM, Neale BM,
Fagerness JA, Mathews CA, Arnold PD, Evans PD, Gamazon ER, Davis
LK, et al: Genome-wide association study of obsessive-compulsive
disorder. Mol Psychiatry. 18:788–798. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schonrock N, Humphreys DT, Preiss T and
Götz J: Target gene repression mediated by miRNAs miR-181c and
miR-9 both of which are down-regulated by amyloid-β. J Mol
Neurosci. 46:324–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu C, Xu B, Yuan P, Ott J, Guan Y, Liu Y,
Liu Z, Shen Y, Yu D and Lin D: Genome-wide examination of genetic
variants associated with response to platinum-based chemotherapy in
patients with small-cell lung cancer. Pharmacogenet Genomics.
20:389–395. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Damgaard T, Knudsen LM, Dahl IM, Gimsing
P, Lodahl M and Rasmussen T: Regulation of the CD56 promoter and
its association with proliferation, anti-apoptosis and clinical
factors in multiple myeloma. Leuk Lymphoma. 50:236–246. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sud A, Del Bono EA, Haines JL and Wiggs
JL: Fine mapping of the GLC1K juvenile primary open-angle glaucoma
locus and exclusion of candidate genes. Mol Vis. 14:1319–1326.
2008.PubMed/NCBI
|
|
19
|
Matsui A, Tran M, Yoshida AC, Kikuchi
SSUM, Ogawa M and Shimogori T: BTBD3 controls dendrite orientation
toward active axons in mammalian neocortex. Science. 342:1114–1118.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Q, Zhao Z, Shang J and Xia W: Targets
and candidate agents for type 2 diabetes treatment with
computational bioinformatics approach. J Diabetes Res.
2014:7639362014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Y, Lin MC, Yao H, Wang H, Zhang AQ,
Yu J, Hui CK, Lau GK, He ML, Sung J and Kung HF:
Lentivirus-mediated RNA interference targeting enhancer of zeste
homolog 2 inhibits hepatocellular carcinoma growth through
down-regulation of stathmin. Hepatology. 46:200–208. 2007.
View Article : Google Scholar : PubMed/NCBI
|
